3-iodobenzylguanidine has been researched along with Cancer, Radiation-Induced in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caron, HN; Clement, SC; Tytgat, GA; van Eck-Smit, BL; van Rijn, RR; van Santen, HM; van Trotsenburg, AS | 1 |
Bertolazzi, L; De Bernardi, B; Di Cataldo, A; Gambini, C; Garaventa, A; Haupt, R; Pizzitola, MR; Villavecchia, G | 1 |
Dewit, LG; Hoefnagel, CA; Liem, IH; ten Bokkel Huinink, WW; Valdés Olmos, RA; van Tinteren, H | 1 |
Brans, B; Dierckx, RA; Kaufman, JM; Laureys, G; Monsieurs, M; Thierens, H | 1 |
4 other study(ies) available for 3-iodobenzylguanidine and Cancer, Radiation-Induced
Article | Year |
---|---|
Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Hypothyroidism; Infant; Male; Neoplasms, Radiation-Induced; Neuroblastoma; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms | 2015 |
Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Hypothyroidism; Infant; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2003 |
Iodine-123 metaiodobenzylguanidine in the assessment of late cardiac effects from cancer therapy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasms, Radiation-Induced; Radionuclide Imaging; Stroke Volume | 1996 |
Thyroidal uptake and radiation dose after repetitive I-131-MIBG treatments: influence of potassium iodide for thyroid blocking.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Dose-Response Relationship, Radiation; Drug Administration Schedule; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Neoplasms, Radiation-Induced; Neuroendocrine Tumors; Potassium Iodide; Premedication; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Thyrotropin | 2002 |